Metyrosine

CHEMBL1200862 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
195.2 g/mol
LogP
-1.6
Phase
4

This drug reduces the production of certain stress hormones called catecholamines by blocking a key enzyme in their synthesis. It is used to manage a rare adrenal gland tumor called pheochromocytoma before and during surgery.

Molecular Weight

195.2100 g/mol

LogP

-1.60

TPSA

83.60 Ų

Lipinski RO5

Pass

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@](N)(Cc1ccc(O)cc1)C(=O)O

InChI

InChI=1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)/t10-/m0/s1

Molecular Formula

C10H13NO3

HBD / HBA

3 / 4

Rotatable Bonds

3

Heavy Atoms

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

This drug reduces the production of certain stress hormones called catecholamines by blocking a key enzyme in their synthesis. It is used to manage a rare adrenal gland tumor called pheochromocytoma before and during surgery.

Yes, Metyrosine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200862. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 441350. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.